National Project Implementation Plan - NVBDCP
National Project Implementation Plan - NVBDCP
National Project Implementation Plan - NVBDCP
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
(a) To enhance the<br />
effectiveness of<br />
government response<br />
to control malaria and<br />
eliminate kala-azar.<br />
(This will be achieved<br />
by increase in the<br />
number of people<br />
benefiting from<br />
effective prevention,<br />
diagnosis and<br />
treatment services for<br />
malaria control and<br />
kala-azar elimination).<br />
For malaria:<br />
(i) Percentage of fever cases in project<br />
districts receiving a malaria test result no<br />
later than the day after the first contact 11 .<br />
(ii) Percentage of individuals in project<br />
areas belonging to eligible ITN target<br />
population who slept under an ITN during<br />
the previous night.<br />
For kala-azar:<br />
(iii) At least 50% of sampled blocks which<br />
at baseline have not achieved the<br />
elimination goal of less than one kala-azar<br />
case per 10,000 persons, will achieve the<br />
elimination goal by endline.<br />
Review current strategies<br />
and make tactical<br />
changes to the program<br />
plan to improve<br />
effectiveness<br />
Develop clear lessons<br />
about effective strategies<br />
that can be brought to<br />
scale and support the<br />
design of the next phase<br />
of the program<br />
Component One: Improving Access to and Use of Malaria Prevention and<br />
Control Services<br />
1.a. Control of<br />
Malaria<br />
a. i. Percentage of population in<br />
high-risk project areas protected<br />
by LLINs or IRS.<br />
a. ii. Percentage of RDT positive<br />
cases in project districts receiving<br />
ACT no later than the day after<br />
the first contact 12 .<br />
a. iii Percentage of designated<br />
providers of malaria diagnosis and<br />
treatment 13 who have not had an<br />
ACT or RDT stock out during the<br />
last 3 months<br />
a. iv Percentage of villages with a<br />
trained designated provider of<br />
malaria diagnosis and treatment<br />
services.<br />
District-level: to make tactical<br />
changes to the program plan<br />
to improve effectiveness and<br />
correct problems.<br />
State and central level: to<br />
adjust training and<br />
supervision activities; to<br />
identify problems requiring<br />
comprehensive change to the<br />
program plan.<br />
Establish results based<br />
management system to guide<br />
financial investments.<br />
Component Two: Improving Access to and Use of Services for Elimination of<br />
Kala-azar<br />
11 Indicator a.ii is likely to be highly correlated with PDO (i), because in rural areas with limited range of service<br />
providers, individuals who have access to an RDT should also have access to ACT. Population survey data will<br />
also indicate where care was sought. The ideal indicator to assess ACT use would be the % of Pf positive cases in<br />
the population who were given ACT no later that the day after the fever started. But it is not possible to measure<br />
directly because: (a) not all fever cases will seek and receive a test result from designated providers, and (b) not<br />
all fever cases who receive a test result will be Pf positive as most do not have malaria or have only Pv. The ACT<br />
treatment indicator for Pf+ cases can be estimated indirectly, from health service data. The PAD is not proposing<br />
this as a PDO indicator as it cannot be estimated from surveys with adequate precision. It will however be<br />
calculated routinely from service data.<br />
12 “Adults” here would mean individuals 15 years or older. Cases in this age group having a positive test for Pf<br />
will be expected to receive an ACT blister pack, which will be easy to measure in surveys. Younger age-groups<br />
are expected to receive loose artesunate and sulfadoxine-pyrimethamine tablets, which will be difficult to identify<br />
in surveys. Current blood examination rates suggest that a majority of blood tests are currently conducted in the<br />
15+ years age group. Also see footnote #1.<br />
13 These individuals are ASHAs and other providers and Multi-Purpose Health Workers.<br />
96